Table 1 Demographic characteristics of the subjects in clinical study I.
From: Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
Characteristics | AR68 0.5 mg/ml (n = 22) | Placebo (n = 23) | p value | |
|---|---|---|---|---|
n (%) | n (%) | |||
Sex | Male | 8 (36.36) | 6 (26.09) | 0.530 |
Female | 14 (63.64) | 17 (73.91) | ||
Age | Mean ± SD | 42.4 ± 8.10 | 42.4 ± 6.69 | 0.546 |
|---|---|---|---|---|
Median | 44.00 | 43.00 | ||
Min, Max | 22.00, 53.00 | 26.00, 53.00 | ||
20 < | 0 (0.00) | 0 (0.00) | ||
20–29 | 2 (9.09) | 1 (4.35) | ||
30–39 | 3 (13.64) | 6 (26.09) | ||
40–49 | 14 (63.63) | 13 (56.52) | ||
≥ 50 | 3 (13.64) | 3 (13.04) |
